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200,000 deaths worldwide (2). 63 IAV contains eight genomic segments encoding for at least ten proteins. Six genomic 64 segments (segments 1, 2, 3, 5, 7 and 8) encode the eight core "internal" proteins PB2, PB1, 65 PA, NP, M1, NS1 and NS2, as well as the ion channel M2. These segments can also encode a 66 variety of accessory proteins known to influence pathogenesis and virulence (reviewed in (3, 67 4) ). Segments 4 and 6 encode for the two surface glycoproteins haemagglutinin (HA) and 68 neuraminidase (NA) respectively (5, 6) and virus strains are divided into subtypes according 69 to the antigenicity of these proteins. 70
Vaccination is the primary public health measure to reduce the impact of influenza 71 epidemics and pandemics, principally using inactivated viruses chosen to antigenically match 72 the currently circulating virus strains or newly emerging viruses of pandemic concern. 73 However, before efficient vaccine production can commence, high-yielding candidate 74 vaccine viruses (CVVs) need to be prepared. Seasonal CVVs are widely produced by 75 classical reassortment. This process involves co-infecting embryonated hens' eggs with the 76 vaccine virus along with a high yielding "donor" virus adapted to growth in eggs (most 77 commonly the A/Puerto Rico/8/34 strain, or "PR8"). The highest yielding viruses that contain 78 the glycoproteins of the vaccine virus are then selected. Recombinant influenza viruses are 79 also made by reverse genetics (RG) (7-9), which relies on the transfection of cells with 80 plasmids engineered to express both viral genomic RNA and proteins from each of the eight 81 segments and hence initiate virus production; the resultant virus is subsequently amplified in 82 eggs. When making RG CVVs, typically the six segments encoding core proteins (backbone) 83 are derived from the donor strain whereas the two segments encoding the antigens are 84 derived from the vaccine virus. Classical reassortment has the advantage that it allows for the 85 fittest natural variant to be selected but it can be time consuming. In the case of a pandemic, 86 large quantities of vaccine must be made available quickly. Moreover, RG is the only viable 87 method for production of CVVs for potentially pandemic highly pathogenic avian influenza 88 viruses, since it allows for removal of genetic determinants of high pathogenicity in the virus 89 genome, as vaccines are manufactured in biosafety level 2 laboratories. A limited number of 90 donor strains for IAV vaccine manufacture currently exist. Although PR8 is widely used, 91 reassortant viruses based on it do not always grow sufficiently well for efficient vaccine 92 manufacture. In the case of the 2009 H1N1 pandemic (pdm09), vaccine viruses grew poorly 93 in eggs compared with those for previous seasonal H1N1 isolates (10) , resulting in 94 manufacturers struggling to meet demand. Thus, there is a clear need for new reagents and 95 methods for IAV production, particularly for pandemic response. 96
In recent years, several approaches have been employed to improve antigen yield of 97 candidate vaccine viruses made by reverse genetics. These have involved empirical testing 98 and selection of PR8 variants (11, 12) , as well as targeted approaches such as making 99 chimeric genes containing promoter and packaging signal regions of PR8 while encoding the 100
The PR8 virus strain PA-X has relatively low shut-off activity. 126
Previous work has noted variation in apparent activity of PA-X proteins from 127 different strains of virus, with the laboratory adapted-strain WSN showing lower activity than 128 many other strains (33). Re-examination of evidence concerning a postulated proteolytic 129 activity of PA (43) suggested that lower PA-X activity might also be a feature of the PR8 130 strain. To test this, the ability of PR8 segment 3 gene products to inhibit cellular gene 131 expression was compared to that of two avian virus-derived PA segments (from 132 A/chicken/Rostock/34 [H7N1; FPV] and A/turkey/England/50-92/91 [H5N1; T/E]. Avian 133 QT-35 (Japanese quail fibrosarcoma) cells were transfected with a consistent amount of a 134 plasmid encoding luciferase under the control of a constitutive RNA polymerase II promoter 135 (pRL) and increasing amounts of the IAV cDNAs (in pHW2000-based RG plasmids), or as a 136 negative control, the maximum amount of the empty pHW2000 vector. Luciferase expression 137 was measured 48 h later and expressed as a % of the amount obtained from pRL-only 138 transfections. Transfection of a 4-fold excess of empty pHW2000 vector over the luciferase 139 reporter plasmid had no significant effect on luciferase expression, whereas co-transfection of 140 the same amount of either the FPV or T/E segments suppressed activity to around 10% of the 141 control ( Fig 1B) . Titration of the FPV and T/E plasmids gave a clear dose-response 142 relationship, giving estimated EC 50 values of 24 ± 1.1 ng and 32 ± 1.1 ng respectively. In 143 contrast, the maximum amount of the PR8 plasmid only inhibited luciferase expression by 144 around 30% and an EC 50 value could not be calculated, indicating a lower ability to repress 145 cellular gene expression. Similarly low inhibitory activity of the PR8 segment 3 was seen in a 146 variety of other mammalian cell lines (data not shown), suggesting it was an intrinsic feature 147 of the viral gene, rather than a host-or cell type-specific outcome. 148
Several studies have shown the X-ORF to be important in host cell shut-off function 149 and virulence of [44] [45] [46] . To further explore the influence of X-ORF sequences on 150 virus strain-specific host cell shut-off, mutations were constructed in segment 3 in which PA-151 X expression was either hindered (via mutation of the frameshift site [FS]) or altered by the 152 insertion of premature termination codons (PTCs 1-4; silent in the PA ORF) such that C-153 terminally truncated forms of PA-X would be expressed ( Figure 1A ). QT-35 cells were co-154 transfected with the pRL plasmid and a fixed amount of WT, FS or PTC plasmids and 155 luciferase expression measured 48 h later. As before, the WT FPV and T/E PA-Xs reduced 156 luciferase activity by approximately 5-10 fold, while WT PR8 PA-X had no significant effect 157 ( Figure 1C ). Introducing the FS mutation into both PR8 and T/E segment 3 significantly 158 increased luciferase activity relative to the WT construct. Truncation of the PR8 PA-X to 225 159 AA or less (PTC mutations 1-3) significantly improved shut-off activity, although not to the 160 levels seen with the WT avian virus polypeptides, while the PTC4 truncation had no effect. In 161 contrast, none of the PTC mutations significantly affected activity of the T/E PA-X, although 162 there was a trend towards increased activity from the PTC2, 3 and 4 truncations 163
Low activity could be due to decreased expression and/or decreased activity of To examine this, expression of the low activity PR8 and high activity FPV PA-X constructs 165 were compared by in vitro translation reactions in rabbit reticulocyte lysate. Translation of 166 segment 3 from both PR8 and FPV produced both full length PA and similar quantities of a 167 minor polypeptide species of the expected size for PA-X whose abundance decreased after 168 addition of the FS mutation or whose electrophoretic mobility was altered in stepwise fashion 169 after C-terminal truncation with the PTC1-4 mutations ( Figure 1D ). This suggested that 170 differences in shut-off potential were not linked to intrinsic differences in PA-X protein 171 synthesis. To confirm the identity of the PR8 in vitro translated polypeptides, 172 immunoprecipitation of IVT products with sera raised either against the N-terminal domain 173 of PA, or an X-ORF derived polypeptide or pre-immune sera (30) were performed ( Figure  174 1E). WT PA-X was clearly visible in samples immunoprecipitated with anti-PA-X and anti-175 PA-N but not the pre-immune serum, where it co-migrated with the product from the 176 delC598 plasmid, a construct in which cytosine 598 of segment 3 (the nucleotide skipped 177 during the PA-X frameshifting event (47)) had been deleted to put the X-ORF into the same 178 reading frame as the N-terminal PA domain ( Figure 1E, lanes 2 and 7) . In contrast, only 179 background amounts of protein were precipitated from the FS IVT (lane 3). Faster migrating 180 polypeptide products from the PTC3 and 4 plasmids showed similar reactivities to WT PA-X 181 (lanes 5 and 6) whereas the product of the PTC1 plasmid was only precipitated by anti-PA-N 182 (lane 4), as expected because of the loss of the epitope used to raise the PA-X antiserum 183 ( Figure 1A ). Overall therefore, the PR8 PA-X polypeptide possessed lower shut-off activity 184 than two avian virus PA-X polypeptides despite comparable expression in vitro, and its 185 activity could be modulated by mutation of the X-ORF. In order to further characterise the role of PA-X as a virulence determinant, we tested 191 the panel of high and low activity mutants in the chicken embryo pathogenicity model. 192
Embryonated hens' eggs were infected with PR8-based viruses containing either PR8 or T/E 193 WT or mutant segment 3s and embryo viability was monitored at 2 days post infection (p.i.) 194 by candling. Both WT PR8 and the WT 7:1 reassortant with the T/E segment 3 viruses had 195 killed over 50% of the embryos by this point (Figures 2A and B ). Truncation of PA-X by the 196 PTC mutations led to small improvements in embryo survival, although none of the 197 differences were statistically significant. However, embryo lethality was significantly 198 reduced to below 20% following infection with the PR8 FS virus compared with PR8 WT 199 virus. A similar reduction in lethality was seen for the T/E FS virus, although the difference 200 was not statistically significant. This reduction in embryo pathogenicity following ablation of 201 PA-X expression suggested potential utility as a targeted mutation in the PR8 backbone used 202 to make CVVs. Accordingly, to characterise the effects of mutating PR8 PA-X over the 203 period used for vaccine manufacture, embryo survival was monitored daily for 72 h. Eggs 204 infected with WT PR8 showed 45% embryo survival at 2 days p.i. and all were dead by day 3 205 ( Figure 2C ). However, the PR8 FS infected eggs showed a statistically significant 206 improvement in survival compared to WT, with 80% and 30% survival at days 2 and 3, 207 respectively. Embryos infected with PR8 expressing the C-terminally truncated PTC1 form 208 of PA-X showed an intermediate survival phenotype with 60% and 20% survival at days 2 209 and 3, respectively. 210
To further assess the effects of mutating PA-X, the chicken embryos were examined 211 for gross pathology. WT PR8 infection resulted in smaller, more fragile embryos with diffuse 212 reddening, interpreted as haemorrhages ( Figure 2D ). In comparison, the PA-X null FS 213 mutant-infected embryos remained intact, were visibly larger and less red. To quantitate these 214 observations, embryos were scored blind for gross pathology. Taking uninfected embryos as 215 a baseline, it was clear that WT PR8 virus as well as the PA-X truncation mutants induced 216 severe changes to the embryos ( Figure 2E ). In contrast, the PA-X null FS mutant caused 217 significantly less pathology. The WT 7:1 T/E reassortant virus gave less overt pathology than 218 WT PR8 but again, reducing PA-X expression through the FS mutation further reduced 219 damage to the embryos ( Figure 2E ). Similar trends in pathology were also seen with 7:1 PR8 220 reassortant viruses containing either WT or FS mutant versions of FPV segment 3 (data not 221 shown). 222
Examination of haematoxylin and eosin (H&E) stained sections through the embryos 223 revealed pathology in numerous organs including the brain, liver and kidney ( Figure 3 ). In 224 the brain of embryos infected with WT virus there was marked rarefaction of the neuropil, 225 few neurons were identifiable, and there was accumulation of red blood cells ( Figure 3C ). In 226 the liver of embryos infected with WT virus the hepatic cords were disorganised, and the 227 hepatocytes were often separated by large pools of red blood cells ( Figure 3D ). In the kidney 228 of embryos infected with WT virus, tubules were often lined by degenerate epithelial cells 229 (characterised by loss of cellular detail). In all cases the pathology noted in WT virus-infected 230 embryos was also present in the FS virus-infected embryos but at a reduced severity. Thus 231 overall, disruption of PA-X expression in PR8 resulted in significantly less pathogenicity in 232 chick embryos. 233
Reduced pathogenicity in vivo following loss of PA-X expression could be due to a 234 replication deficiency of the virus, although the viruses replicated equivalently in mammalian 235
MDCK cells (data not shown). To test if replication did differ in ovo, infectious virus titres 236
were obtained (by plaque titration on MDCK cells) from the allantoic fluid of embryonated 237 hens' eggs infected with the panels of PR8 and T/E viruses at 2 days p.i.. However, there 238 were no significant differences in titres between either PR8 or T/E WT and PA-X mutant 239 viruses ( Figures 4A, B ). Since the reduced pathogenicity phenotype in ovo on loss of PA-X 240 expression was more pronounced for viruses with PR8 segment 3 than the T/E gene, embryos 241 from PR8 WT and segment 3 mutant-infected eggs were harvested at 2 days p.i., washed, 242 macerated and virus titres from the homogenates determined. Titres from embryos infected 243 with the PR8 FS and PTC4 viruses were slightly (less than 2-fold) reduced compared to 244 embryos infected with PR8 WT virus ( Figure 4C ), but overall there were no significant 245 differences in titres between the viruses. To see if there were differences in virus localisation 246 in tissues between PR8 WT and FS viruses, immunohistochemistry was performed on chick 247 embryo sections to detect viral NP as a marker of infected cells. NP positive cells were seen 248 in blood vessels throughout the head and body of both PR8 WT and FS-infected embryos; 249 liver, heart and kidney are shown as representatives ( Figure 4D ), indicating that the 250 circulatory system had been infected. However, there were no clear differences in virus 251 localisation between embryos infected with WT and FS viruses. 252 Overall therefore, the loss of PA-X expression reduced IAV pathogenicity in chick 253 embryos, as assessed by mortality curves and both gross and histopathological examination 254 of embryo bodies. This reduced pathogenicity did not appear to correlate with reduced 255 replication or altered distribution of the virus in ovo. 256
257
Ablating PA-X expression alters virion composition 258 Other viruses encode host-control proteins with mRNA endonuclease activity, 259
including the SOX protein of murine gammaherpesvirus MHV68 whose expression has been 260 shown to also modulate virion composition (48). Also, egg-grown IAV titre and HA yield do 261 not always exactly match, with certain problematic candidate vaccine viruses (CVVs) 262 containing lower amounts of HA per virion (16, 49, 50) . Accordingly, we compared the 263 relative quantities of virion structural proteins between PA-X expressing and PA-X null 264 viruses. Two pairs of viruses were tested: either an entirely PR8-based virus, or a 7:1 265 reassortant of PR8 with FPV segment 3, both with or without the FS mutation. Viruses were 266 grown in eggs as before and purified from allantoic fluid by density gradient 267 ultracentrifugation before polypeptides were separated by SDS-PAGE and visualised by 268 staining with Coomassie blue. To ensure that overall differences in protein loading did not 269 bias the results, 3-fold dilutions of the samples were analysed. From the gels, the major virion 270 components of both WT and FS virus preparations could be distinguished: NP, the two 271 cleaved forms of haemagglutinin, HA1 and HA2, the matrix protein, M1 and in lower 272 abundance, the polymerase proteins ( Figures 5A, B CVVs. Therefore, the effect of incorporating the PA-X FS mutation into CVV mimics 291 containing glycoproteins of different IAV subtypes was examined. Reasoning that a benefit 292 might be most apparent for a poor-yielding strain, 6:2 CVV mimics containing the 293 glycoprotein genes from the A(H1N1)pdm09 vaccine strain, A/California/07/2009 (Cal7) 294 with the six internal genes from PR8, with or without the FS mutation in segment 3, were 295 generated. Growth of these viruses in embryonated hens' eggs was then assessed by 296 inoculating eggs with either 100, 1,000 or 10,000 PFU per egg (modelling the empirical 297 approach used in vaccine manufacture to find the optimal inoculation dose) and measuring 298 HA titre at 3 days p.i.. Both viruses grew best at an inoculation dose of 100 PFU/egg, but 299 final yield was both relatively low (as expected, ~ 64 HAU/50 μl) and insensitive to input 300 dose, with average titres varying less than 2-fold across the 100-fold range of inocula ( Figure  301 6A). However, at each dose, the 6:2 FS virus gave a higher titre (on average, 1.6-fold) than 302 the parental 6:2 reassortant. In order to assess HA yield between the WT and FS viruses on a 303 larger scale, comparable to that used by WHO Essential Regulatory Laboratories (ERLs) 304 such as the National Institute for Biological Standards and Control, UK, 20 eggs per virus 305 were infected at a single inoculation dose. In this experiment, the average HA titre of the FS 306 virus was over 3 times higher than the WT 6:2 virus ( Figure 6B ). To further determine the 307 consistency of these results, HA titre yields were assessed from two independently rescued 308 reverse genetics stocks of the Cal7 6:2 CVV mimics with or without the PR8 PA-X gene as 309 well as another 6:2 CVV mimic bearing the glycoproteins from the A/England/195/2009 310 (Eng195) A(H1N1)pdm09 strain. HA yield from different stocks was assessed in independent 311 repeats of both small-(5 eggs for each of three different inoculation doses, taking data from 312 the dose that gave maximum yield) and large-scale (20 eggs per single dose of virus) 313 experiments. Examination of the average HA titres showed considerable variation between 314 independent experiments ( Figure 6C ). However, when plotted as paired data points, it was 315 obvious that in every experiment, the FS viruses gave a higher yield than the parental 6:2 316 reassortant and on average, there were 2.7-and 3.8-fold higher HA titres with the segment 3 317 FS mutation for Cal7 and Eng195 respectively (Table 1) . 318
To directly assess HA protein yield, viruses were partially purified by 319 ultracentrifugation of pooled allantoic fluid through 30% sucrose cushions. Protein content 320 was analysed by SDS-PAGE and Coomassie staining, either before or after treatment with N-321 glycosidase F (PNGaseF) to remove glycosylation from HA and NA. Both virus preparations 322 gave polypeptide profiles that were clearly different from uninfected allantoic fluid processed 323 in parallel, with obvious NP and M1 staining, as well other polypeptide species of less certain 324 origin ( Figure 6D ). Overall protein recovery was higher in the FS virus than the WT 325 reassortant virus (compare lanes 3 and 4 with 5 and 6), but the poor yields of these viruses 326 made unambiguous identification of the HA polypeptide difficult. However, PNGaseF 327 treatment led to the appearance of a defined protein band migrating at around 40 kDa that 328 probably represented de-glycosylated HA1, and this was present in appreciably higher 329 quantities in the 6:2 FS preparation (compare lanes 4 and 6). Therefore, equivalent amounts 330 of glycosylated or de-glycosylated samples from the Cal7 WT and FS reassortants were 331 analysed by SDS-PAGE and western blotting using anti-pdm09 HA sera. The western blot 332 gave a clear readout for HA1 content, confirmed the mobility shift upon de-glycosylation and 333 showed increased amounts of HA1 in the 6:2 FS samples ( Figure 6D lower panel) . 334
Quantitative measurements of the de-glycosylated samples showed that the 6:2 FS virus gave 335 1.9-fold greater HA1 yield than the WT reassortant. To test the reproducibility of this finding, 336 HA1 yield was assessed by densitometry of de-glycosylated HA1 following SDS-PAGE and 337 western blot for partially purified virus from 9 independent experiments with the Cal7 and 338
Eng195 reassortants. When examined as paired observations, it was evident that in 8 of the 9 339 experiments, the FS viruses gave greater HA yields than the parental virus, with only one 340 experiment producing a lower amount ( Figure 6E) . In one large-scale experiment, the HA1 341 yield of 6:2 FS was approximately 20-fold higher compared to its 6:2 counterpart. However, 342 in all other experiments, the 6:2 FS virus gave between 1.5 and 3-fold increases in HA1 yield 343 when compared with the 6:2 virus. When the outlier was discounted (as possibly resulting 344 from an artefactually low recovery for the WT sample), average HA1 yield from the other 8 345 experiments showed 1.9-and 2.4-fold improvements with the segment 3 FS mutation for 346 Cal7 and Eng195 respectively (Table 1) . 347
The HA yield of CVVs with pdm09 glycoproteins has been shown to be improved by 348 engineering chimeric HA genes which contain signal peptide and transmembrane 349 domain/cytoplasmic tail sequences from PR8 HA and the antigenic region of the HA gene 350 from Cal7 (19, 20) . To test if these gains were additive with those seen with the FS mutation, 351
we introduced the NIBRG-119 construct, which is a segment 4 with the ectodomain coding 352 region of Cal7 HA and all other sequences (3′and 5′-noncoding regions, signal peptide, 353 transmembrane domain, and cytoplasmic tail) from PR8 (19) into 6:2 CVV mimics with the 354 WT A(H1N1)pdm09 NA gene and a PR8 backbone with or without the PA-X mutation. 355
Viruses bearing the NIBRG-119 HA did not agglutinate chicken red blood cells (data not 356 shown) so HA yield from eggs was assessed by SDS-PAGE and western blot of partially 357 purified virus. Chimeric HA viruses containing the FS backbone showed an average HA 358 yield improvement of 1.54-fold compared to the WT backbone counterpart, across 359 independent small-and large-scale experiments (Table 1) . Thus, the FS mutation is 360 compatible with other rational strategies for increasing egg-grown reverse genetics vaccines. 361
Following on from this, several pairs of CVV mimics were made with glycoproteins 362 from different IAV strains with either WT or FS mutant PR8 segment 3. These included 363 viruses with glycoproteins of potentially pandemic strains such as highly pathogenic avian 364 virus A/turkey/Turkey/1/2005 (H5N1), as well as low pathogenic avian strains 365 A/mallard/Netherlands/12/2000 (H7N3), A/chicken/Pakistan/UDL-01/2008 (H9N2) and 366 A/mallard/Netherlands/10/99 (H1N1), as well as the human H3N2 strain, A/Hong Kong/1/68, 367 and an early seasonal H3N2 isolate, A/Udorn/307/72 (Table 1) . HA yield in eggs was 368 assessed from both the small-scale and large-scale experimental conditions described earlier, 369 by measuring HA titre and HA1 yield from partially purified virus particles. In general, the 370 two techniques were in agreement (Table 1) . Ablating PA-X expression moderately improved 371 HA1 yields of some of the CVVs tested: 1.5-fold for the avian H7N3 strain, 372 A/mallard/Netherlands/12/2000 and 1.3-fold for the human H3N2 A/Udorn/307/72 strain. 373
Other CVVs showed lesser or effectively no increases. However, in no case, did ablation of 374 PA-X appear to be detrimental to the growth of CVVs. 375 376 Discussion 377 Here we show that ablating expression of PA-X resulted in reduced pathogenicity in 378 the chicken embryo model despite the PR8 PA-X protein having relatively low host cell shut-379 off activity compared to PA-X from other IAV strains. Although loss of PA-X expression had 380 no effect on infectious titres in eggs, subtle differences in virion composition were observed, 381 and more importantly, the HA yield from poor growing 6:2 reassortant vaccine analogues 382 containing the HA and NA segments from A(H1N1) pdm09 strains was significantly 383 improved. 384
The majority of studies examining the effect of loss of PA-X expression on IAV 385 pathogenicity have used mice as the experimental system. As discussed above, in most cases, 386 the outcome has been increased virulence (30, (34) (35) (36) (37) (38) (39) (40) , but several studies have found the 387 opposite effect, with PA-X deficiency reducing pathogenicity in mice (37, 41, 42) . In adult 388 bird challenge systems using chickens and ducks infected with a highly pathogenic H5N1 389 virus, abrogating PA-X expression caused increased virulence (35) . In our infection model of 390 embryonated hens' eggs, loss of PA-X expression markedly reduced the pathogenicity in 391 chick embryos. Thus like PB1-F2, another trans-frame encoded IAV accessory protein (51), 392 the impact of PA-X expression on viral pathogenicity seems to vary according to both host 393 and virus strain, but not in a fashion that can simply be correlated with mammalian or avian 394
settings. 395
In previous studies, changes in virulence phenotypes following loss of PA-X 396 expression have been associated with its host cell shut-off function. In the virus strains used, 397 whether from high pathogenicity or low pathogenicity IAV strains, the PA-X polypeptides 398 were shown to significantly affect host cell gene expression. Here, despite PR8 PA-X failing 399 to repress cellular gene expression, a strong phenotypic effect was seen in chicken embryos 400 following loss of PA-X expression. Furthermore, these effects on pathogenicity were more 401 pronounced in an otherwise WT PR8 virus than in a 7:1 reassortant with segment 3 from the 402 highly pathogenic H5N1 avian influenza T/E strain which encodes a PA-X with strong host 403 cell shut-off activity. This lack of correlation between repression of cellular gene expression 404 in avian cells and phenotypic effects in chicken embryos suggests that the PR8 PA-X protein 405 may harbour a function unrelated to host cell shut-off. The PR8 PA-X protein has been 406 proposed to inhibit stress granule formation, but via a mechanism linked to its endonuclease 407 activity and therefore presumably reflecting shut-off activity (52). Alternatively, it could be 408 that the PR8 PA-X polypeptide only exhibits repressive function in specific cell types, such 409 as those of the chorioallantoic membrane (the primary site of virus replication in eggs) or the 410 chick embryo itself. However, since we found low shut-off activity from it in a variety of 411 cells from different species and conversely, no great cell specificity of high activity PA-X 412 polypeptides (data not shown), we do not favour this hypothesis. 413
Several studies have found that sequences in the X-ORF make positive contributions 414 to the shut-off activity of 37, 39, 45, 46) . In contrast, here we found that for both 415 PR8 and T/E strains of the polypeptide, removal of X-ORF sequences actually increased 416 shut-off activity compared to the WT polypeptide. The effect was relatively modest and in 417 the case of PR8, did not confer equivalent activity to the full-length avian virus PA-X 418 polypeptides ( Figure 1C) . A similar outcome of greater inhibition from a truncated PA-X 419 polypeptide was seen with a triple reassortant swine influenza virus (42), suggesting that the 420 X-ORF can harbour negative as well as positive regulatory polymorphisms. 421
In some but not all studies, effects of PA-X mutations on viral pathogenicity have 422 been associated with differences in virus replication in vivo. While Jagger et al., (30) did not 423 attribute the increased virulence in mice upon loss of 1918 H1N1 PA-X to virus replication, 424
Gao and colleagues found that increased virulence in mice on loss of H5N1 PA-X was 425 associated with increased titres of Δ PA-X viruses in the lungs, brains and blood of infected 426 mice (34, 39) . Similarly, Hu et al. found that increased virulence in chicken, ducks and mice 427 of a ∆ PA-X H5N1 virus was associated with increased virus titres in the host (35). Given the 428 postulated role of PA-X-mediated repression of cellular gene expression in controlling host 429 responses to infection, it is reasonable to hypothesise that these differing outcomes reflect the 430 variable interplay between host and virus that is well known to tip in favour of one or other 431 depending on exact circumstance (53). Our present study, where loss of a PA-X with little 432 apparent ability to modulate host gene expression had no significant effect on virus titres in 433 allantoic fluid or the chick embryos themselves, but nevertheless reduced pathogenicity, do 434 not support this hypothesis. However, differences in progeny virion composition in the form 435 of altered ratios of HA to NP and M1 between WT and FS viruses were seen. This may 436 differentially affect their ability to infect specific cell types, as the amount of virus receptor 437 varies between different tissue types and is a known determinant of tissue tropism of 438 influenza viruses (reviewed in (54, 55)). 439
Our findings have direct implications for HA yield of vaccine viruses in eggs. 440
Ablating PA-X expression did not affect yield from eggs of high growth viruses such as PR8 441 or 6:2 reassortant CVV mimics containing glycoproteins of human H3N2 strains, or 442 potentially pandemic low pathogenicity avian H9N2 or H1N1 viruses. However, mutation of 443 the PR8 PA-X gene in the background of a CVV analogue containing the HA and NA 444 segments from poor growing strains, such as A(H1N1)pdm09 viruses or a potentially 445 pandemic avian H7N3 isolate, increased HA yield by around 2-fold. The mechanism of 446 improved yield of certain virus subtypes but not others on loss of PA-X expression is unclear. 447
Others have found that mutating the FS site of PR8 PA-X has subtle effects on viral protein 448 expression in vitro, including lower levels of M1 (45), perhaps explaining the changes in HA 449 to M1 ratio we see. Beneficial outcomes to HA yield may only be apparent in low-yielding 450 strains where perhaps viral rather than cellular factors are limiting. Alternatively, changes in 451 virion composition between WT and FS viruses could result in subtype/strain-specific effects 452 depending on the balance between HA and NA activities (56). Whatever the mechanism, in 453 no case was loss of PA-X expression detrimental to yield of CVVs, when assessing HA yield 454 of a wide range of different influenza A subtypes/strains. This approach of modifying the 455 PR8 donor backbone therefore potentially supplies a 'universal' approach that can be applied 456 to all CVVs that is additive with, but without the need for, generation and validation of, 457 subtype/strain-specific constructs, as is required for strategies based on altering the 458 glycoprotein genes. This could be beneficial to improve antigen yield in a pandemic setting 459 where manufacturers are required to produce large amounts of vaccine quickly. 
Site-directed mutagenesis 500
The QuikChange® Lightning site-directed mutagenesis kit (Stratagene) was used according 501 to the manufacturer's instructions. Primers used for site-directed mutagenesis of the segment 502 3 gene were designed using the primer design tool from Agilent technologies. The strategies 503 used to disrupt the frameshift site (FS) as well as generating C-terminally truncated versions 504 of PA-X via PTCs were as described (30); the cited study used the PTC1 construct. 505 506 507
Protein analyses 508
Coupled in vitro transcription-translation reactions were carried out in rabbit reticulocyte 509 lysate supplemented with 35 S-methionine using the Promega TNT system according to the 510 manufacturer's instructions. SDS-PAGE followed by autoradiography was performed 511 according to standard procedures. Immunoprecipitations were performed as previously 512 described (70). Transfection-based reporter assays to assess host cell shut-off by PA-X 513 (described previously (30)) were performed by co-transfecting QT-35 cells with a reporter 514 plasmid containing the Renilla luciferase gene along with pHW2000 plasmids expressing the 515 appropriate segment 3 genes with or without the desired PA-X mutations. 48 h post-516 transfection, cells were lysed and luciferase activity measured on a Promega GloMax 96-well 517
Microplate luminometer using the Promega Renilla Luciferase system. 518 519
Reverse genetics rescue of viruses 520
All viruses used in this study were made by reverse genetics. 293T cells were transfected 521 with eight pHW2000 plasmids each encoding one of the influenza segments using 522
Lipofectamine™ 2000 (Invitrogen). Cells were incubated for 6 hours post-transfection before 523 medium was replaced with DMEM serum-free virus growth medium. At 2 days post-524 transfection, 0.5 µg/ml TPCK trypsin (Sigma) was added to cells. Cell culture supernatants 525 were harvested at 3 days post-transfection. 293T cell culture supernatants were clarified and 526 used to infect 10-11 day-old embryonated hens' eggs. At 3 days p.i., eggs were chilled over-527 night and virus stocks were partially sequenced to confirm identity. 528 529 RNA extraction, RT-PCR and sequence analysis. Primers and purified DNA were sent to GATC biotech for Sanger sequencing (Lightrun 537 method). Sequences were analysed using the DNAstar software. 538 539
Virus titration 540
Plaque assays, TCID 50 assays and haemagglutination assays were performed according to 541 standard methods (71). MDCK or MDCK-SIAT cells were used for infectious virus titration, 542 and infectious foci were visualised by either toluidine blue or immunostaining for influenza 543 NP and visualising using a tetra-methyl benzidine (TMB) substrate. 544 545
Virus purification and analysis 546
Allantoic fluid was clarified by centrifugation twice at 6,500 x g for 10 mins. Virus was then 547 partially purified by ultracentrifugation at 128,000 x g for 1.5 hours at 4ºC through a 30% 548 sucrose cushion. For further purification, virus pellets were resuspended in PBS, loaded onto 549 15-60% sucrose/PBS density gradients and centrifuged at 210,000 x g for 40 mins at 4ºC. 550
Virus bands were extracted from gradients and virus was pelleted by ultracentrifugation at 551 128,000 x g for 1.5 hours at 4ºC. Pellets were resuspended in PBS and aliquots treated with 552 N-glycosidase F (New England Biolabs), according to the manufacturer's protocol. Virus 553 pellets were lysed in Laemmli sample buffer and separated by SDS-PAGE on 10% or 12% 554 polyacrylamide gels under reducing conditions. Protein bands were visualised by Coomassie 555 blue staining (Imperial TM protein stain, Thermo Scientific) or detected by immunostaining in 556 western blot. Coomassie stained gels were scanned and bands quantified using ImageJ 557 software. Western blots were scanned on a Li-Cor Odyssey Infrared Imaging system v1.2 558 after staining with the appropriate antibodies and bands were quantified using ImageStudio 559
Lite software (Odyssey). 560 561 Chick embryo pathogenesis model 562
Ten-day old embryonated hens' eggs were inoculated via the allantoic cavity route with 1000 563 PFU in 100 μl per egg or mock (serum-free medium only) infected. Embryo viability was 564 subsequently determined by examination of veins lining the shell (which collapse on death) 565 and embryo movement (for a few minutes). At 2 -3 days p.i. (depending on experiment), 566 embryos were killed by chilling, washed several times in PBS and then scored blind for overt 567 pathology by two observers in each experiment. Scores were 0 = normal, 1 = intact but with 568 dispersed haemorrhages, 2 = small, fragile embryo with dispersed haemorrhages. For 569 histology, embryos were decapitated, washed several times in PBS, imaged and fixed for 570 several days in 4% formalin in PBS. Two embryos per virus condition were sectioned 571 longitudinally and mounted onto paraffin wax. Tissue sections were cut and mounted onto 572 slides and stained with haematoxylin and eosin (H&E) by the Easter Bush Pathology Service. 573
Further sections were examined by immunohistofluorescence performed for influenza NP 574 (62). Sections were deparaffinised and rehydrated and heat-induced antigen retrieval was 575 performed using sodium citrate buffer (10 mM sodium citrate, 0.05% Tween20, pH 6.0). 576
Sections were stained with anti-NP antibody followed by an Alexa fluor-conjugated 577 secondary antibody. Pre-immune bleed serum was also used to confirm specificity of staining 578 by anti-NP antibody. Sections were mounted using ProLong Gold anti-fade reagent 579 containing DAPI (Invitrogen). Stained tissue sections were scanned using a Nanozoomer XR 580 (Hamamatsu) using brightfield or fluorescence settings. Images were analysed using the NDP 581 view 2.3 software (Hamamatsu). 
